The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing

被引:362
作者
Deweese, Joseph E. [1 ]
Osheroff, Neil [1 ,2 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med Hematol Oncol, Nashville, TN 37232 USA
基金
美国国家卫生研究院;
关键词
BENZENE METABOLITES; INFANT LEUKEMIA; RELIGATION REACTION; DOUBLE HELIX; METAL-ION; MLL GENE; IN-VITRO; FORMS; ALPHA; BETA;
D O I
10.1093/nar/gkn937
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topoisomerase II is an essential enzyme that is required for virtually every process that requires movement of DNA within the nucleus or the opening of the double helix. This enzyme helps to regulate DNA under- and overwinding and removes knots and tangles from the genetic material. In order to carry out its critical physiological functions, topoisomerase II generates transient double-stranded breaks in DNA. Consequently, while necessary for cell survival, the enzyme also has the capacity to fragment the genome. The DNA cleavage/ligation reaction of topoisomerase II is the target for some of the most successful anticancer drugs currently in clinical use. However, this same reaction also is believed to trigger chromosomal translocations that are associated with specific types of leukemia. This article will familiarize the reader with the DNA cleavage/ligation reaction of topoisomerase II and other aspects of its catalytic cycle. In addition, it will discuss the interaction of the enzyme with anticancer drugs and the mechanisms by which these agents increase levels of topoisomerase II-generated DNA strand breaks. Finally, it will describe dietary and environmental agents that enhance DNA cleavage mediated by the enzyme.
引用
收藏
页码:738 / 748
页数:11
相关论文
共 157 条
[1]   PLASMA-CONCENTRATIONS OF PHYTO-ESTROGENS IN JAPANESE MEN [J].
ADLERCREUTZ, H ;
MARKKANEN, H ;
WATANABE, S .
LANCET, 1993, 342 (8881) :1209-1210
[2]   STRAND SPECIFICITY OF THE TOPOISOMERASE-II MEDIATED DOUBLE-STRANDED DNA CLEAVAGE REACTION [J].
ANDERSEN, AH ;
CHRISTIANSEN, K ;
ZECHIEDRICH, EL ;
JENSEN, PS ;
OSHEROFF, N ;
WESTERGAARD, O .
BIOCHEMISTRY, 1989, 28 (15) :6237-6244
[3]   Type II topoisomerases as targets for quinolone antibacterials: turning Dr. Jekyll into Mr. Hyde [J].
Anderson, VE ;
Osheroff, N .
CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (05) :337-353
[4]   Toprim - a conserved catalytic domain in type IA and II topoisomerases, DnaG-type primases, OLD family nucleases and RecR proteins [J].
Aravind, L ;
Leipe, DD ;
Koonin, EV .
NUCLEIC ACIDS RESEARCH, 1998, 26 (18) :4205-4213
[5]   ISOLATION AND CHARACTERIZATION OF A HUMAN CDNA CLONE ENCODING A NOVEL DNA TOPOISOMERASE-II HOMOLOG FROM HELA-CELLS [J].
AUSTIN, CA ;
FISHER, LM .
FEBS LETTERS, 1990, 266 (1-2) :115-117
[6]   SITE-SPECIFIC DNA CLEAVAGE BY MAMMALIAN DNA TOPOISOMERASE-II INDUCED BY NOVEL FLAVONE AND CATECHIN DERIVATIVES [J].
AUSTIN, CA ;
PATEL, S ;
ONO, K ;
NAKANE, H ;
FISHER, LM .
BIOCHEMICAL JOURNAL, 1992, 282 :883-889
[7]  
Austin CA, 1998, BIOESSAYS, V20, P215, DOI 10.1002/(SICI)1521-1878(199803)20:3<215::AID-BIES5>3.0.CO
[8]  
2-Q
[9]   Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies [J].
Azarova, Anna M. ;
Lyu, Yi Lisa ;
Lin, Chao-Po ;
Tsai, Yuan-Chin ;
Lau, Johnson Yiu-Nam ;
Wang, James C. ;
Liu, Leroy F. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (26) :11014-11019
[10]   Mutagenic properties of topoisomerase-targeted drugs [J].
Baguley, BC ;
Ferguson, LR .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1998, 1400 (1-3) :213-222